跳转至内容
Merck
CN

64166

2-羟基乙基甲基丙烯酸酯

puriss., ≥99.0% (GC)

别名:

HEMA, 乙二醇单甲基丙烯酸酯, 甲基丙烯酸2-羟乙酯

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
CH2=C(CH3)COOCH2CH2OH
化学文摘社编号:
分子量:
130.14
EC Number:
212-782-2
UNSPSC Code:
12162002
MDL number:
Beilstein/REAXYS Number:
1071583
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


vapor density

5 (vs air)

vapor pressure

0.01 mmHg ( 25 °C)

grade

puriss.

assay

≥99.0% (GC)

contains

~0.001% hydroquinone monomethyl ether as stabilizer

refractive index

n20/D 1.453

bp

67 °C/3.5 mmHg (lit.)

density

1.071 g/mL at 20 °C, 1.073 g/mL at 25 °C (lit.)

SMILES string

CC(=C)C(=O)OCCO

InChI

1S/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3

InChI key

WOBHKFSMXKNTIM-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under 2-羟基乙基甲基丙烯酸酯


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

222.8 °F - closed cup

flash_point_c

106 °C - closed cup

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Nina Yu Kostina et al.
Biomacromolecules, 13(12), 4164-4170 (2012-11-20)
Five poly(betaine) brushes were prepared, and their resistance to blood plasma fouling was studied. Two carboxybetaines monomers were copolymerized with 2-hydroxyethyl methacrylate (HEMA) to prepare novel hydrogels. By increasing the content of the zwitterionic comonomer, a 4-fold increase in the
Duncan Chege et al.
Journal of acquired immune deficiency syndromes (1999), 65(5), 517-525 (2013-11-22)
To evaluate if systemic murine malarial infection enhances HIV susceptibility through parasite-induced mucosal immune alterations at sites of HIV sexual exposure. Malaria and HIV have a high degree of geographical overlap and interact substantially within coinfected individuals. We used a
Brendan P Purcell et al.
Biomaterials, 33(31), 7849-7857 (2012-07-28)
Poor cell engraftment in the myocardium is a limiting factor towards the use of bone marrow derived cells (BMCs) to treat myocardial infarction (MI). In order to enhance the engraftment of circulating BMCs in the myocardium following MI, we have